Literature DB >> 25919846

Why patients with severe personality disorders are overmedicated.

Joel Paris1.   

Abstract

Emotionally unstable personality disorder (EUPD), more widely known as borderline personality disorder (BPD), has long been considered a clinical challenge. Patients meeting criteria for these diagnoses are emotionally dysregulated, impulsive, and involved in troubled relationships; in clinical settings, they may threaten suicide or attempt it and are frequently seen in emergency departments. Patients with BPD can be treatment resistant, even when clinically depressed, to both pharmacotherapy and standard types of psychotherapy. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919846     DOI: 10.4088/JCP.14com09441

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  The State of Overmedication in Borderline Personality Disorder: Interpersonal and Structural Factors.

Authors:  Rosa Shapiro-Thompson; Sarah K Fineberg
Journal:  Curr Treat Options Psychiatry       Date:  2022-03-04

Review 2.  The Use of Computer-Driven Technologies in the Treatment of Borderline Personality Disorder: A Systematic Review.

Authors:  Alexandre Hudon; Caroline Gaudreau-Ménard; Marissa Bouchard-Boivin; Francis Godin; Lionel Cailhol
Journal:  J Clin Med       Date:  2022-06-26       Impact factor: 4.964

Review 3.  Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies.

Authors:  Jutta Stoffers-Winterling; Ole Jakob Storebø; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2020-06-05       Impact factor: 5.285

4.  Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.

Authors:  Juan C Pascual; Ana Martín-Blanco; Joaquim Soler
Journal:  CNS Drugs       Date:  2021-08-09       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.